We are live on ! Find out more
WHWK

Whitehawk Therapeutics
WHWK

33 hedge funds and large institutions have $26.1M invested in Whitehawk Therapeutics in 2020 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 2

240% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 5

123% more capital invested

Capital invested by funds: $11.7M → $26.1M (+$14.4M)

57% more funds holding

Funds holding: 21 → 33 (+12)

1.23% more ownership

Funds ownership: 1.54% → 2.76% (+1.2%)

Holders
33
Holders Change
+12
Holders Change %
+57.14%
% of All Funds
0.67%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
7
Reduced
2
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
IC
Ikarian Capital
Texas
+$5.53M
2
Citadel Advisors
Citadel Advisors
Florida
+$2.88M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$1.66M
4
BFM
Boothbay Fund Management
New York
+$583K
5
PHP
Parkman Healthcare Partners
Connecticut
+$421K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$464K
2
TCM
Tekla Capital Management
Massachusetts
-$322K
3
HighTower Advisors
HighTower Advisors
Illinois
-$46K
4
Goldman Sachs
Goldman Sachs
New York
-$37K
5
TSS
Two Sigma Securities
New York
-$31K
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$7.79M – – –
IC
2
Ikarian Capital
Texas
$5.91M +$5.53M +262,831 New
Citadel Advisors
3
Citadel Advisors
Florida
$3.08M +$2.88M +136,736 New
Renaissance Technologies
4
Renaissance Technologies
New York
$2.23M -$464K -22,046 -18%
Acadian Asset Management
5
Acadian Asset Management
Massachusetts
$1.77M +$1.66M +78,722 New
Vanguard Group
6
Vanguard Group
Pennsylvania
$1.76M +$33.4K +1,586 +2%
BFM
7
Boothbay Fund Management
New York
$624K +$583K +27,728 New
JIC
8
Johnson Investment Counsel
Ohio
$481K – – –
PHP
9
Parkman Healthcare Partners
Connecticut
$450K +$421K +20,000 New
Qube Research & Technologies (QRT)
10
Qube Research & Technologies (QRT)
United Kingdom
$382K +$311K +14,759 +662%
Ameriprise
11
Ameriprise
Minnesota
$296K +$277K +13,141 New
Two Sigma Advisers
12
Two Sigma Advisers
New York
$241K +$226K +10,727 New
Geode Capital Management
13
Geode Capital Management
Massachusetts
$183K +$10.3K +490 +6%
BlackRock
14
BlackRock
New York
$171K +$63 +3 +0%
NRS
15
Neville Rodie & Shaw
New York
$150K – – –
Northern Trust
16
Northern Trust
Illinois
$85K +$8.9K +423 +13%
US Bancorp
17
US Bancorp
Minnesota
$75K – – –
Two Sigma Investments
18
Two Sigma Investments
New York
$59K +$55.4K +2,633 New
VF
19
Virtu Financial
New York
$55K +$51.8K +2,463 New
Arrowstreet Capital
20
Arrowstreet Capital
Massachusetts
$54K +$50.1K +2,382 New
CL
21
CSS LLC
Illinois
$45K +$42.1K +2,000 New
LC
22
Lindbrook Capital
California
$45K +$42.1K +2,000 New
Jane Street
23
Jane Street
New York
$30K +$28.5K +1,354 New
Russell Investments Group
24
Russell Investments Group
United Kingdom
$30K +$28.9K +1,373 New
BW
25
Bison Wealth
Georgia
$26K +$1.41K +67 +6%
1
2

WHWK Hedge Fund Activity: Q3 2020 in Review

33 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Whitehawk Therapeutics (WHWK) for Q3 2020, worth a combined $26.1M — up 123% from $11.7M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new WHWK positions and 5 closed out — a net gain of 12 holders — while 7 added to existing stakes and 2 trimmed.

The largest buyer was Ikarian Capital, opening a new position worth an estimated $5.53M. The largest seller was Renaissance Technologies, cutting an estimated $464K.

  • 33 institutional investors held Whitehawk Therapeutics (WHWK) as of Q3 2020, up from 21 in Q2 2020.
  • Funds reported $26.1M of Whitehawk Therapeutics stock for Q3 2020, up 123% quarter-over-quarter.
  • 17 funds opened new Whitehawk Therapeutics positions in Q3 2020 and 5 closed out, a net change of +12 holders.
  • The largest Whitehawk Therapeutics buyer in Q3 2020 was Ikarian Capital, an estimated $5.53M added.
  • The largest Whitehawk Therapeutics seller in Q3 2020 was Renaissance Technologies, an estimated $464K sold.

Based on aggregated 13F filings for Q3 2020.